Showing 8551-8560 of 21414 results for "".
Utilizing Hybrid Closed-Loop Technology for T1D Pediatric Patients
https://reachmd.com/programs/diabetes-discourse/utilizing-hybrid-closed-loop-technology-for-t1d-pediatric-patients/17885/Tune in to learn about a recent study on hybrid closed-loop technology in young children with type 1 diabetes.CGM in the Real T2D World
https://reachmd.com/programs/cme/cgm-real-t2d-world/50982/Continuous glucose monitoring (CGM) is still recommended for all individuals with diabetes, including those with type 2 diabetes (T2D). Despite this, its use in managing T2D has not been as widespread as expected. New evidence has recently highlighted the benefits of CGM for people with T2D. Join ouToward Safe and Effective Insulin Initiation
https://reachmd.com/programs/diabetes-discourse/toward-safe-and-effective-insulin-initiation/4579/Type 2 diabetes is a progressive disease and most patients will eventually need insulin to achieve euglycemia. Early and aggressive management to lower blood glucose reduces the risk of complications of the disease. It can be challenging for health care professionals to decide which treatment regimeDo We Need to Temper our Enthusiasm for Incretin-Based Therapy?
https://reachmd.com/programs/diabetes-discourse/do-we-need-to-temper-our-enthusiasm-for-incretin-based-therapy/5947/There have been impressive results with incretin-based therapy for patients with type 2 diabetes: improved A1C, beta-cell preservation and weight loss are some of the benefits. But do healthcare professionals need to temper their enthusiasm for this novel therapy? Join host Dr. Steven Edelman and hiManaging Obesity & Pre-Diabetes When Lifestyle Modifications Fail
https://reachmd.com/programs/primary-care-today/managing-obesity-pre-diabetes-when-lifestyle-modifications-fail/7818/What options are available to our patients at risk of diabetes after other modifications fall short of target goals?Can Autologous Stem Cells Reverse the Damage of a Heart Attack?
https://reachmd.com/programs/heart-matters/can-autologous-stem-cells-reverse-the-damage-of-a-heart-attack/5258/Stem cell therapies across multiple disciplines continue to demonstrate promising results. How successful are autologous cardiac stem cell treatments proving to be at regenerating cardiac tissue after a heart attack? Which patients would be the best candidates for this procedure, and when might thisClosing Gaps in Care for Patients with T2D & CV Disease
https://reachmd.com/programs/diabetes-discourse/closing-gaps-in-care-for-patients-with-t2d-cv-disease/15148/Learn more about obstacles to care for patients with type 2 diabetes and cardiovascular disease from the recent COORDINATE study.Sexual Dysfunction: Communication is the Key
https://reachmd.com/programs/diabetes-discourse/sexual-dysfunction-communication-is-the-key/4603/A certified diabetes educator can help both physicians and patients when it comes to sexual dysfunction. Sexual dysfunction is experienced by over half of all women with diabetes, and approximately 32 percent of men with type 1 and 46 percent of men with type 2. So, it is critical to provide good coInvestigating Beta Cell Dysfunction and Immune Activity in Early T1D
https://reachmd.com/programs/diabetes-discourse/beta-cell-dysfunction-immune-activity-early-t1d/67278/Residual beta cells may persist after a type 1 diabetes (T1D) diagnosis, but how well do they continue to function? Tune in to hear Dr. Edward Phelps discuss research he presented at the 2026 European Association for the Study of Diabetes Annual Meeting that examined glucose-stimulated calcium respoDiabetes Highlights from ENDO 2013 - the 95th Annual Meeting of The Endocrine Society
https://reachmd.com/programs/conference-coverage/diabetes-highlights-from-endo-2013-the-95th-annual-meeting-of-the-endocrine-society/6823/Diabetes Highlights from ENDO, the 95th Annual Meeting of The Endocrine Society. The Endocrine Society is the world's oldest, largest, and most active organization devoted to research on hormones and the clinical practice of endocrinology. In this program, you will hear from global thought leaders